Advertisement
Advertisement

KALV

KALV logo

KalVista Pharmaceuticals, Inc. Common Stock

14.88
USD
Sponsored
+0.47
+3.30%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

14.88

0.00
0.00%

KALV Earnings Reports

Positive Surprise Ratio

KALV beat 24 of 36 last estimates.

67%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

KalVista Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Jan 08, 2026, KALV reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.63 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 22.62 million, with a --% difference. The market reacted with a +6.19% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q4 2026, KalVista Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 6.19%, changed from $15.82 before the earnings release to $16.80 the day after.
The next earning report is scheduled for --.
Based on -- analysts, KalVista Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement